ACTIVE

CABINET DE RHUMATOLOGIE ET MEDECINE D'EXPERTISE DR. C. RIBBENS

Export PDF

Financial year 2025 · Closed on 30/09/2025

Net result3,3 k €-88,9 %over 1 year
Revenue36,9 k €-55,4 %over 1 year
Equity221 k €+1,1 %over 1 year

Identity

Source · BCE/KBO

CABINET DE RHUMATOLOGIE ET MEDECINE D'EXPERTISE DR. C. RIBBENS is a Private limited company incorporated in 2014. Its main activity is: Technical testing and analysis. Its registered office is in Liège.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0563.776.371
Incorporation
08/10/2014
Legal form
Private limited company
Registered office
Boulevard Piercot 14/91
4000 Liège · WallonieSee on map
Contributed capital
18 600,00 €
Latest accounts
30/09/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 11 filings

Trend over 11 financial years

20252024202320222021
Income statement
Revenue36,9 k €82,6 k €73,3 k €117,2 k €134,3 k €
EBITDA13,3 k €57,6 k €37 k €82,3 k €80,1 k €
Operating result1,4 k €43,1 k €22,3 k €68,8 k €69,1 k €
Net result3,3 k €29,6 k €12,3 k €44,3 k €44,3 k €
Balance sheet
Equity221 k €218,5 k €189,7 k €178,2 k €134,7 k €
Total assets253,2 k €257,3 k €229,8 k €225 k €199,5 k €
Cash64,7 k €101,3 k €78,3 k €64 k €41,4 k €
Debts32,2 k €38,8 k €40,1 k €46,8 k €64,8 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 30/09/2025

1 active

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Clio RIBBENS
MandateAdministrator - manager01/10/2014 → 2016 accountsended

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/10/202401/10/202301/10/202201/11/202101/11/202001/11/2019
Closing of the financial year30/09/202530/09/202430/09/202330/09/202231/10/202131/10/2020
Length of the financial year12 months12 months12 months11 months12 months12 months
Filing date01/03/202624/02/202527/02/202419/02/202308/04/202206/04/2021
General meeting28/02/202622/02/202518/02/202415/02/202331/03/202231/03/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 11 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/09/202528/02/202601/03/2026FrenchPDF
Micro model30/09/202422/02/202524/02/2025FrenchPDF
Micro model30/09/202318/02/202427/02/2024FrenchPDF
Micro model30/09/202215/02/202319/02/2023FrenchPDF
Micro model31/10/202131/03/202208/04/2022FrenchPDF
Micro model31/10/202031/03/202106/04/2021FrenchPDF
Micro model31/10/201911/04/202014/04/2020FrenchPDF
Micro model31/10/201830/03/201902/04/2019FrenchPDF
Micro model31/10/201731/03/201801/04/2018FrenchPDF
Abridged model31/10/201630/03/201705/04/2017FrenchPDF
Abridged model31/10/201525/03/201627/03/2016FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/09/2025

1 active

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Clio RIBBENS
MandateAdministrator - manager01/10/2014 → 2016 accountsended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates24/01/2022
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - DIVERS - OBJET - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - ANNEE COMPTABLE
    PDF
  • Other17/10/2014
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings11 filings
Mandates
Clio RIBBENS
2014201520162017201820192020202120222023202420252026
CABINET DE RHUMATOLOGIE ET MEDECINE D'EXPERTISE DR. C. RIBBENS
Boulevard Piercot 14/91, 4000 LiègeBoulevard Piercot 14 bte 91, 4000 Liège
Administrator - manager
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Boulevard Piercot 14/91, 4000 LiègeCurrent
accounts 2025
Accounts 2025 · 2026-00046188
Boulevard Piercot 14 bte 91, 4000 Liège
accounts 2023 → 2024
Accounts 2024 · 2025-00038289
Boulevard Piercot 14/91, 4000 Liège
accounts 2022
Accounts 2022 · 2023-00028893
Boulevard Piercot 14 bte 91, 4000 Liège
accounts 2021
Accounts 2021 · 2022-20001657

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
CABINET DE RHUMATOLOGIE ET MEDECINE D'EXPERTISE DR. C. RIBBENSCurrent
accounts 2021 → 2025
Accounts 2025 · 2026-00046188

Events

  1. 2025
    Annual accounts 20253,3 k €↓
  2. 2024
    Annual accounts 202429,6 k €↑
  3. 2023
    Annual accounts 202312,3 k €↓
  4. 2022
    Annual accounts 202244,3 k €↓
  5. 2021
    Annual accounts 202144,3 k €↓
  6. 2020
    Annual accounts 202053,6 k €↑
  7. 2019
    Annual accounts 201928,1 k €↑
  8. 2018
    Annual accounts 201815,2 k €↓
  9. 2017
    Annual accounts 201735 k €↑
  10. 2016
    Annual accounts 201634,6 k €↑
  11. 2015
    Annual accounts 201525,9 k €
  12. 08/10/2014
    IncorporationPrivate limited company